Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F B Müller

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
Circulation|January 1, 1986
Identification of the direct vasodilator effect of milrinone with an isolated limb preparation in patients with chronic congestive heart failureR J Cody, F B Müller, S H Kubo, et al.
Journal of Cardiovascular Pharmacology|January 1, 1986
Cardiac and vascular beta-adrenoceptor-mediated responses before and during treatment with bisoprolol or atenololP Bolli, F B Müller, L Linder, et al.
American Journal of Hypertension|December 1, 1991
Hemodynamic responses to verapamil monotherapy in patients with renal diseaseT Lenz, F B Müller, J E Sotelo, et al.
Journal of Cardiovascular Pharmacology|January 1, 1982
The place of the calcium antagonist verapamil in antihypertensive therapyF R Bühler, U L Hulthén, W Kiowski, et al.
Journal of Clinical Hypertension|September 1, 1986
Dose initiation of calcium antagonists in the treatment of hypertensionF B Müller, P Erne, M Hotz, et al.
Hypertension (Dallas, Tex. : 1979)|December 1, 1990
Psychosomatic factors in borderline hypertensive subjects and offspring of hypertensive parentsC Perini, F B Müller, U Rauchfleisch, et al.
The American Journal of Medicine|December 15, 1986
Calcium antagonists and the second drug for hypertensive therapyF B Müller, P Bolli, L Linder, et al.
Schweizerische Medizinische Wochenschrift|December 8, 1984
[Aggression inhibition and increased sympathetic nervous reactivity in the development of essential hypertension]C Perini, F B Müller, U Rauchfleisch, et al.
European Heart Journal|November 1, 1987
Calcium antagonist induced vasodilation in peripheral, coronary and cerebral vasculature as important factors in the treatment of elderly hypertensivesP Erne, D Conen, W Kiowski, et al.
Circulation|December 1, 1989
Mechanisms of action and clinical use of calcium antagonists in hypertensionW Kiowski, P Bolli, P Erne, et al.
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Circulation|January 1, 1986
Identification of the direct vasodilator effect of milrinone with an isolated limb preparation in patients with chronic congestive heart failureR J Cody, F B Müller, S H Kubo, et al.
Journal of Cardiovascular Pharmacology|January 1, 1986
Cardiac and vascular beta-adrenoceptor-mediated responses before and during treatment with bisoprolol or atenololP Bolli, F B Müller, L Linder, et al.
American Journal of Hypertension|December 1, 1991
Hemodynamic responses to verapamil monotherapy in patients with renal diseaseT Lenz, F B Müller, J E Sotelo, et al.
Journal of Cardiovascular Pharmacology|January 1, 1982
The place of the calcium antagonist verapamil in antihypertensive therapyF R Bühler, U L Hulthén, W Kiowski, et al.
Journal of Clinical Hypertension|September 1, 1986
Dose initiation of calcium antagonists in the treatment of hypertensionF B Müller, P Erne, M Hotz, et al.
Hypertension (Dallas, Tex. : 1979)|December 1, 1990
Psychosomatic factors in borderline hypertensive subjects and offspring of hypertensive parentsC Perini, F B Müller, U Rauchfleisch, et al.
The American Journal of Medicine|December 15, 1986
Calcium antagonists and the second drug for hypertensive therapyF B Müller, P Bolli, L Linder, et al.
Schweizerische Medizinische Wochenschrift|December 8, 1984
[Aggression inhibition and increased sympathetic nervous reactivity in the development of essential hypertension]C Perini, F B Müller, U Rauchfleisch, et al.
European Heart Journal|November 1, 1987
Calcium antagonist induced vasodilation in peripheral, coronary and cerebral vasculature as important factors in the treatment of elderly hypertensivesP Erne, D Conen, W Kiowski, et al.
Circulation|December 1, 1989
Mechanisms of action and clinical use of calcium antagonists in hypertensionW Kiowski, P Bolli, P Erne, et al.
Pageof 6